Marrone Bio Innovations to Present at H.C. Wainwright 22nd Annual Global Investment Conference
DAVIS, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today announced that management will present at the H.C. Wainwright 22nd Annual Global Investment Conference taking place virtually September 14 – 16, 2020.
Jim Boyd, Chief Financial Officer, is scheduled to host a virtual presentation during the conference as follows and will participate in one-on-one meetings with Chief Executive Officer Kevin Helash throughout the day.
H.C. Wainwright 22nd Annual Global Investment Conference
A live audio webcast and archive of the conference presentation will be available using the webcast link above. For more information on the H.C. Wainwright 22nd Annual Global Investment Conference or to schedule a one-on-one meeting with management, please contact your H.C. Wainwright representative.
About Marrone Bio Innovations
Learn more about Marrone Bio Innovations at www.marronebio.com. We also use our investor relations website, https://investors.marronebio.com, as well as our corporate Twitter account, @Marronebio, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Follow us on social media: Twitter, LinkedIn and Instagram.
Marrone Bio Innovations Forward Looking Statements
Investor Relations Contact:
Connectivity Management: Change is Gonna Come